Page de couverture de Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 "AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".

Ce que les auditeurs disent de Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.